Examination of efficacy of olmesartan on peripheral insulin sensitivity in Japanese patients with type 2 diabetes

Trial Profile

Examination of efficacy of olmesartan on peripheral insulin sensitivity in Japanese patients with type 2 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 13 May 2016

At a glance

  • Drugs Olmesartan medoxomil (Primary)
  • Indications Essential hypertension; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Dec 2011 Actual end date (Dec 2011) added as reported by University Hospital Medical Information Network - Japan.
    • 03 Dec 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 10 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top